Serum IL-6 and PTX3 predict severe outcome from COVID-19 in ambulatory subjects: Impact for future therapeutic decisions

• Josh Poorbaugh ,

  Contributed equally to this work with: Josh Poorbaugh, Jonathan T. Sims

  Roles Conceptualization, Data curation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America

  ⨯
• Jonathan T. Sims ,

  Contributed equally to this work with: Josh Poorbaugh, Jonathan T. Sims

  Roles Conceptualization, Data curation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America

  https://orcid.org/0000-0001-8599-2157

  ⨯
• Lin Zhang,

  Roles Conceptualization, Formal analysis, Visualization, Writing – review & editing

  Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America

  ⨯
• Ching-Yun Chang,

  Roles Data curation, Formal analysis, Writing – review & editing

  Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America

  ⨯
• Richard E. Higgs,

  Roles Conceptualization, Data curation, Writing – review & editing

  Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America

  ⨯
• Ajay Nirula,

  Roles Conceptualization, Resources, Writing – review & editing

  Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America

  ⨯
• Robert J. Benschop

  Roles Conceptualization, Resources, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: rbenschop@lilly.com

  Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America

  https://orcid.org/0000-0001-6313-5218

  ⨯